• Approved for the treatment of erectile dysfunction
• Also approved for specialist use in treating:
  • Pulmonary hypertension (see section 2.5.1a) 
  • Secondary Raynaud’s disease. 

• 10mg and 20mg tablets
• 5mg tablets (once daily)

For treatment of erectile dysfunction. 

NB: generic tadalafil is no longer subject to SLS restrictions. The Cialis^® brand remains subject to SLS restrictions and should be prescribed accordingly. 

For information regarding use in Raynauds disease see chapter 2.5.1

5mg, 10mg and 20mg tablets

For treatment of erectile dysfunction

NB: generic vardenafil is no longer subject to SLS restrictions. The Levitra^® brand remains subject to SLS restrictions and should be prescribed accordingly.

• Vitaros® 3mg/g cream
• Muse® 500microgram, and 1mg.

Treatment with alprostadil cream (Vitaros®) is NOT approved for use in County Durham and Tees Valley

• 25microgram/phentolamine 2mg solution for injection. 
• Approved as first choice intracavernosal injection option.
  • Approved for the treatment of erectile dysfunction (in accordance with SLS criteria)

• 10microgram,  20 microgram injection (vials and dual chamber devices)
• Approved as the second choice intracavernosal injection option.
• Caverject® dual chamber injections are easier to use and less expensive than the vials.
• Viridal Duo® 10, 20 and 40 microgram starter pack and dual chamber injection 
  • Approved for the treatment of erectile dysfunction (in accordance with SLS criteria)